Melanoma Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Melanoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Jan 18, 2019

---

• The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.  
  Armengot-Carbó Miquel et al. Journal of the American Academy of Dermatology 2018 78(5) 920-926.e4
• Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.  
  Fenton G L et al. The British journal of dermatology 2018 Dec
• Current Approaches to Pancreatic Cancer Screening.  
  Chhoda Ankit et al. The American journal of pathology 2019 Jan 189(1) 22-35
• An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile.  
  Li Yang et al. Journal of cellular biochemistry 2018 Dec
• Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine.  
  Tarhini Ahmad et al. Cancer treatment reviews 2018 Dec 718-18
• Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities.  
  Rabbie Roy et al. The Journal of pathology 2018 Dec
• Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test  
  Mirsky Rachel et al. Journal of drugs in dermatology : JDD 2018 Nov 17(11) 1220-1223
• FDA approves ‘precision medicine’ drug for different cancers with same mutation 
  L McGinley, Washington Post, November 26, 2018
• Gene expression profiling in melanoma: past results and future potential.  
  Knackstedt Rebecca W et al. Future oncology (London, England) 2018 Nov
• Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy.  
  Ayers Mark et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov